Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice
Aim: The aim of this study was to evaluate the efficacy and safety of the new ultra-long-acting insulin degludec (Tresiba®) in the treatment of type 2 diabetes in routine clinical practice.Methods: This primary health care clinical observational study included 20 insulin-naïve type 2 diabetic patien...
Zapisane w:
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Endocrinology Research Centre
2015-12-01
|
| Seria: | Сахарный диабет |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.dia-endojournals.ru/jour/article/view/7695 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|